Literature DB >> 5492448

Treatment of Behçet's disease with chlorambucil.

J G Mamo, S A Azzam.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5492448     DOI: 10.1001/archopht.1970.00990040448008

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  17 in total

Review 1.  Immunosuppression in uveitis therapy.

Authors:  R N Van Gelder; H J Kaplan
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Immunosuppressives in uveitis. A preliminary report of experience with chlorambucil.

Authors:  W J Dinning; E S Perkins
Journal:  Br J Ophthalmol       Date:  1975-08       Impact factor: 4.638

3.  Behçet's disease.

Authors:  G P Clunie
Journal:  BMJ       Date:  1992-05-30

Review 4.  Practical treatment recommendations for pharmacotherapy of Behçet's syndrome.

Authors:  H Yazici; C G Barnes
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

5.  Behçet's disease and the alimentary tract.

Authors:  J V Parkin; D G Wight
Journal:  Postgrad Med J       Date:  1975-04       Impact factor: 2.401

6.  High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease.

Authors:  H H Tessler; T Jennings
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

7.  Treatment of Behcet's disease with chlorambucil.

Authors:  D Tricoulis
Journal:  Br J Ophthalmol       Date:  1976-01       Impact factor: 4.638

Review 8.  Oral ulceration and Behçet's syndrome.

Authors:  T Lehner
Journal:  Gut       Date:  1977-06       Impact factor: 23.059

9.  [Symptomatology of Behçet's disease (author's transl)].

Authors:  H Schneider
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1973-07-20

10.  Long-lasting remission of Behcet's disease after chlorambucil therapy.

Authors:  M I Abdalla; N el-D Bahoat
Journal:  Br J Ophthalmol       Date:  1973-09       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.